Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity

business news • news • web article

Eli Lilly said it believes the new data bolsters the case for Mounjaro to be prescribers' first choice for patients with Type 2 diabetes.

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity — image source: sc.cnbcfm.com

read more on www.cnbc.com

1 / 1

Eli Lilly’s Mounjaro shows heart health benefits in head-to-head trial with older diabetes drug Trulicity — image source: sc.cnbcfm.com

❮ ❯

Related Items

Related Lists

Best Music Ever (playlist)

The Best Athletes Of All Time

Best writers of all time

Best Refrigerator Brands